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m’907147 Relatlonof MaximalOxygenUptaketo LeftVentricularFunctionin PatientswithDilated
Cardiomyopathy
R kpu-Bula, A. Roben, M. De Kock,J. Melin,A.-M. D’Hondt,
J.-L. Vanoverachelde.Urrivereityof Louvairf, Brusae/s, fie/gium
Reduced exercise capacity (EC) is a cardinal symptomin patients(pts)
with dilated cardiomyopathy(DCM) and chroniccongestiveheart failure.
Previousstudieshaveshownthatthe severityof reductioninEC inthesepts
correlatedpoorlywiththe degreeof leftventricular(LV)systo[icdysfunction.
As diastolicdysfunctionis commonamongpts witha DCM, we evaluated
the possibilitythat differencesin diastolicLV functioncontributedto their
variableEC. Accordingly, we studied 26 consecutive pts (61 * 12 yrs) with
a DCM (LV end-diastolicdimension>60 mm, shorteningfraction <25’%.)
in NYHA functionalclass I-HI. Their mean ejectionfraction(EF) was 30 +
10%. AIIptswerein sinus rhythm and off fl:blockers at the time of the study.
EC was measured as peak oxygen uptake (VOZ)during a symptom-limited
treadmill exercise (modified Bruce protocol). LV intemaldimensions(m-mode
echo),EF(radionuclideventriculography)anddiastolicfillingparameters(PW
Doppler)were measuredat reet in every pte immediatelybeforeexercise.
Peak VQ rangad from 12t036mUk@min (mean21 + 6)andcorrelatsdwith
the followingparameters:the ratioof earfyto latetransmittalfilling velocities
(E/A ratio, r= O.64,p < 0.001), peak early filling velocity (r= O.77,p < 0.001),
isovolumic relaxation period (r= 0.75, p < 0.001), deceleration time (r= 0.70,
p < 0.001), atrial filling fraction (r= 0.66, p -= 0.001), LV EF (r= 0.39, p =
0.05), meanVcf (r= 0.14, p = ns)and,LVend-diastolicdimensions(r = 0.10,
p = nS).Our data thus indicatethat indicesof diastolicretherthan syetolic
functioncorrelatewithexercisecapacityin ptswithDCM. Thissuggeststhat
LVdiastolicdysfunctionmay playa role in limitingEC inthese pts.
m907148 Characterizationof DifferentTimeCoureeaof Left
andRightVentricularRacoveryAfterLung
Transplantation
C.H. Lorenz,J.E. Loyal,S.S. Klein,V.L. Morgan,E.S. Walker,W.H. Frist,
T.P.Graham,Jr. Barnes-Jewish Hospital, St. Louis, MO, USA, Vandetiilt
Univem”fyMedical Centec Nashville, TN, USA
Cine MRI was used to determine the time-course of changes in ventricular
mase and function after lung transplantation (LT).The studygroupsincluded
65 healthysubjects, 44 studies on 43 patients ,withpulmonary hypertension
beingevaluatedfor LT.and 25 studies on 11 patients following lung trans-
plantation [earfy: -=6mos post-LT,intermediate: 6-16 mos post-LT,and late:
>18 months post-LT]. RV and LV mass,volume and functional parameters
were determined from the tomographic MRI datesets (maasandvolumenor-
malized to body surface area). RV ejectionfraction(RVEF) normalizedinthe
early poat-LTperiod. RV end-diastolicvolumedecreased to below normal
levels early and remained low even in the late studies. RV mass regressed,
but remainedelevated comparedto control.LV mass was belownormalin
the pre-LTgroup,but increasedto slightlyabove normalearly post-LTand
returnedto normal by late post-LT.LVEF normalizedby the intermediate
periodwhileLVEDVnormalizedinthe earlypost-LTperiod.Inaummary,both
functionaland structuralrecoveryoccurs in the early to intermediate peat-LT
perfod forfhe LV. In the RV,structural recovery lags functional recovery,and
RVstruofure isnot Completelynormali.zedby 18monthspost-transplantation.
We speculate that the mechanisms resfxrnsible for these disparate effects
reflect rapid adjuatmenta to preload changes in the LV and more protracted
adjustment to afterload changes in the RV.
Control Pre-LT Earlypost ht. post-LT Latepost-LT
RVEF 60.8k 0.8 45.4k 2.4” 55.8*4.3 64.5l2.2* 59.1+2.4
RVEDVIB6A 74.1+ 1.5 89.8+ 6.7” 66.0+ 8.1 50.9* 3.9* 62.7*7.9*
RVmaaaJB6A 26.1+ 0.5 48.7+ 3.S” 45.0+ 3.9* 30.1+ 2.3” 35.4*4.6*
LVEF 86.8+ 0.6 61.1+ 2.2* 55.8+4.1* 64.1+ 2.1 62.0+ 3.9
LVEDWSSA 65.5+ 1.3 45.S+2.3* 65.2+ 9.1 53.4+4,0” 5S.94C5.2*
LV meas/BSA 87.3 & 1.4 76.1 k 3.4* 95.1 i 5.7* 80.2 k 2.5* S6.S*6.2
“significantlydifferentfrom controlat p <0.05 level
1907-161] hlha,edNitricOxideiSa~*9stiveRi9ht
Ventricular(RV)Inotropein PrimaryPulmonary
Hypertension
P.J.Counihan,J. Gorcsan,Ill, L. Firestone,W.A. Mandarino,W.E. Katz,
M.D. Feldman,S. Murali.Universifyof Pittsburgh, Pitfsbugfr, PA, USA
Inhalednitricoxide (NO) reducespulmonatypressuresin patientswithpri-
marypulmonaryhypertension(PPH). This effect may be due to pulmonary
vaaodilatation. More recently NO has been shown to have direct negative
inotropic effects. Accordingly we hypothesised that the hemodynamic effects
of NO are due in part toa negative RV inotropiceffect.Methods: RV pressure-
area kJops were recorded at baseline and during inhalation of NO 60 ppm,
using transthotacic echo and high-fidelity pressure during WC occlusion in
7 patients (age 42 & 8 yrs) with PPH. RV end-systolic pressure (RVESP),
cardiac output and peak +dP/dt fell significantly with NO. Emax tended to
decrease with a marked right-ward shift in pressure-area loops in W pta
implying a negative inotropic effect (fig).
Baseline No P
RVESP 85+ 19 76~ 17 0.05
PCWP 7*3 9+5 0.10
co 4.3 i 1,4 3.4 * 0.7 0:05
RV + dP/dt 59S & 165 512 & 126 0.05
RVEmax 15.0 +9,0 t2.1 + 6.0 0.10
RVha (on+)
Conclusion: Inhaled NO reduces RV pressurea in PPH which is mediated
in part by a negative inotropic effect on RV performance.
D ,;bro~;907162 DlaatobcDysfunctionin PatientswithCystic
TM. Koelling, L.C. Ginns, K.-T. Khaw, D.M. Systrom, G.W. Dac, T.G. Di
Salvo, M.J. Semigran. Massachusetts General Hospital and Harvard
Medical School, Boaton, MA, USA
Although myocardial fibrosis has been described in autopsy epecimens of
patients with cystic fibrosis (CF) with acute left ventricular failure, no clear
association has been identified between CFand aeymptomatic Ieftventricular
dysfunction. To asseas the possibility of cardiac dysfunction occurring in
CF, we studied 40 patients with advanced CF under evaluation for lung
transplantation with firat-pass radionuclide ventriculography and compared
them to 18 normal controls (NL) and 9 patients with advanced bronchiectaeis
(BR) (ages, 29 + 8,37 + 12”, and 33 + 7 yeara, reapaciively (mean + SD).
‘ p <0.05 vs CF). RVEF for CF (0.34 + 0.07) and BR (0.35 + 0.06) was
lower than NL (0.44+ 0.068). Indicea of left ventricular aystolic and diastolic
fundion are shown in the Table below.
CF EIR NI
LVEF 0.62 + 0.08 0.63 +0.0S 0,62 + 0,06
AtrialFilling‘A 3s * 1s 21 k4* 25 h 12”
17meto Peak Filling/RR 0.25 + 0.07 0.21 +0.0s 0,22 +0.06
Fillinaat 50°A Ltiast.de 54* 13 66 *4* 69* 14*
Conclusions: 1) Patients with advanced lung disease from cystic fibrosia
demonstrate diastolic dysfunction when compared to normal controls and
to patients with bronchiectasis. 2) Patients with long 8tanding cystic fibrosis
may be at risk of congestive heart failure due to impaired left ventricular
relaxation caused by myocardial fibrosis,
907-163 EnhancsdDelineationof PericardialDieeaeesby
Three-DimensionalEchocardiography
T.-L. Hsu, S.J. Ho, J.-J. Wang, S.-P.Wang, M.-S. Chang, R. Kasliwal,
N. Pandian. Division of Cardiolog~ Veterans General Hoapital-Taipei,
Taiwan,Republic of China, TuftaNew England Medical Cente< Boaton, USA
Intrapericerdial abnormalities such as effusion, fibrin, hematoma, tumor and
fat pad could be easily identified by 2-dimensional achocardiography (2DE).
However, the usefulness of voxel-based 3-dimensional echocardiography
(3DE) has not been examined in evaluating of pericardial disease (PD). The
purpose of this study was to assess the diagnostic value of 3DE in the
delineation of intra-pericardial pathologies. Multilane transesophageal 2DE
was performed in 21 patients (pts) including Ioculatad pericerdial effusion
(PE) in 6 pts and circumferential PE in 5 pts, effusive-constriction in 2 pts,
constrictive pericarditis in 2 pts, pericardial cyst inone pt, primary paricardiaf
tumorin one pt and metaatetic tumor in 2 pts. Sequential 2D images were ac-
quirsd and reconstructedby volume rendering. Resu/ts:From the3Ddataset,
